Regeneron Pharmaceuticals, Inc. (BMV:REGN)

Regeneron Pharmaceuticals Statistics

Total Valuation

BMV:REGN has a market cap or net worth of MXN 1.43 trillion. The enterprise value is 1.14 trillion.

Market Cap	1.43T
Enterprise Value	1.14T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Current Share Class	100.78M
Shares Outstanding	n/a
Shares Change (YoY)	-4.39%
Shares Change (QoQ)	-1.29%
Owned by Insiders (%)	3.79%
Owned by Institutions (%)	87.45%
Float	98.52M

Valuation Ratios

The trailing PE ratio is 16.98 and the forward PE ratio is 16.20.

PE Ratio	16.98
Forward PE	16.20
PS Ratio	5.46
PB Ratio	2.51
P/TBV Ratio	2.63
P/FCF Ratio	18.41
P/OCF Ratio	15.33
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.41, with an EV/FCF ratio of 14.69.

EV / Earnings	13.54
EV / Sales	4.43
EV / EBITDA	14.41
EV / EBIT	16.52
EV / FCF	14.69

Financial Position

The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.09.

Current Ratio	4.06
Quick Ratio	3.19
Debt / Equity	0.09
Debt / EBITDA	0.62
Debt / FCF	0.64
Interest Coverage	90.81

Financial Efficiency

Return on equity (ROE) is 15.19% and return on invested capital (ROIC) is 7.27%.

Return on Equity (ROE)	15.19%
Return on Assets (ROA)	6.16%
Return on Invested Capital (ROIC)	7.27%
Return on Capital Employed (ROCE)	10.70%
Revenue Per Employee	17.17M
Profits Per Employee	5.52M
Employee Count	15,106
Asset Turnover	0.37
Inventory Turnover	2.46

Taxes

In the past 12 months, BMV:REGN has paid 10.40 billion in taxes.

Income Tax	10.40B
Effective Tax Rate	11.02%

Stock Price Statistics

The stock price has decreased by -9.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-9.04%
50-Day Moving Average	11,024.12
200-Day Moving Average	14,951.33
Relative Strength Index (RSI)	64.62
Average Volume (20 Days)	315

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.60

Income Statement

In the last 12 months, BMV:REGN had revenue of MXN 261.34 billion and earned 83.97 billion in profits. Earnings per share was 762.93.

Revenue	261.34B
Gross Profit	119.78B
Operating Income	70.12B
Pretax Income	94.37B
Net Income	83.97B
EBITDA	79.75B
EBIT	70.12B
Earnings Per Share (EPS)	762.93

Balance Sheet

The company has 154.87 billion in cash and 49.62 billion in debt, giving a net cash position of 293.91 billion.

Cash & Cash Equivalents	154.87B
Total Debt	49.62B
Net Cash	293.91B
Net Cash Per Share	n/a
Equity (Book Value)	567.83B
Book Value Per Share	5,523.68
Working Capital	248.64B

Cash Flow

In the last 12 months, operating cash flow was 93.01 billion and capital expenditures -15.58 billion, giving a free cash flow of 77.44 billion.

Operating Cash Flow	93.01B
Capital Expenditures	-15.58B
Free Cash Flow	77.44B
FCF Per Share	n/a

Margins

Gross margin is 45.83%, with operating and profit margins of 26.83% and 32.13%.

Gross Margin	45.83%
Operating Margin	26.83%
Pretax Margin	36.11%
Profit Margin	32.13%
EBITDA Margin	30.52%
EBIT Margin	26.83%
FCF Margin	29.63%

Dividends & Yields

This stock pays an annual dividend of 67.63, which amounts to a dividend yield of 0.50%.

Dividend Per Share	67.63
Dividend Yield	0.50%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	6.06%
Buyback Yield	4.39%
Shareholder Yield	4.89%
Earnings Yield	5.89%
FCF Yield	5.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:REGN has an Altman Z-Score of 6.89 and a Piotroski F-Score of 4.

Altman Z-Score	6.89
Piotroski F-Score	4